Tatsuo Oyake

628 total citations
34 papers, 338 citations indexed

About

Tatsuo Oyake is a scholar working on Hematology, Oncology and Infectious Diseases. According to data from OpenAlex, Tatsuo Oyake has authored 34 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 14 papers in Oncology and 8 papers in Infectious Diseases. Recurrent topics in Tatsuo Oyake's work include Neutropenia and Cancer Infections (7 papers), Acute Myeloid Leukemia Research (6 papers) and Antifungal resistance and susceptibility (5 papers). Tatsuo Oyake is often cited by papers focused on Neutropenia and Cancer Infections (7 papers), Acute Myeloid Leukemia Research (6 papers) and Antifungal resistance and susceptibility (5 papers). Tatsuo Oyake collaborates with scholars based in Japan and United States. Tatsuo Oyake's co-authors include Yoji Ishida, Shigeki Ito, Kazunori Murai, M Tomaki, Shugo Kowata, Naoko Kageyama, K Shirato, M. Miura, Haruo Yamauchi and G Tamura and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Tatsuo Oyake

26 papers receiving 329 citations

Peers

Countries citing papers authored by Tatsuo Oyake

Since Specialization

Citations

This map shows the geographic impact of Tatsuo Oyake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsuo Oyake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsuo Oyake more than expected).

Fields of papers citing papers by Tatsuo Oyake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatsuo Oyake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsuo Oyake. The network helps show where Tatsuo Oyake may publish in the future.

Co-authorship network of co-authors of Tatsuo Oyake

This figure shows the co-authorship network connecting the top 25 collaborators of Tatsuo Oyake. A scholar is included among the top collaborators of Tatsuo Oyake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tatsuo Oyake. Tatsuo Oyake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	P11-4 Efficacy and safety of anti-CD38 antibodies in combination with pomalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma 2023 ·Annals of Oncology ·Tsuyoshi Sato, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yoshiaki Okano, (unknown), Shugo Kowata, Tatsuo Oyake, Shigeki Ito	0
2	Association of CD8 + T cells expressing nivolumab-free PD-1 with clinical status in a patient with relapsed refractory classical Hodgkin lymphoma 2023 ·International Journal of Hematology ·Shugo Kowata, (unknown), (unknown), Tsuyoshi Sato, (unknown), (unknown), Akiko Yashima‐Abo, (unknown), Yoshiaki Okano, Tatsuo Oyake, Shigeki Ito	0
3	Lymphoma during pregnancy in Japan: a multicenter retrospective cohort study 2022 ·International Journal of Hematology ·(unknown), Momoko Nishikori, Kimikazu Yakushijin, Shingo Kurahashi, Hideyuki Nakazawa, Yasushi Takamatsu, Yoshinori Hashimoto, Hiro Tatetsu, Yuichiro Nawa, Masahiro Yoshida, Tsutomu Kobayashi, Tatsuo Oyake, Shingo Yano, Aki Oride, Ritsuro Suzuki	5
4	Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine 2021 ·Cancer Science ·Yutaka Shimazu, Shohei Mizuno, Shin‐ichi Fuchida, Kazuhito Suzuki, Nobuhiro Tsukada, (unknown), (unknown), Keisuke Kataoka, Shinichi Kako, Emiko Sakaida, Satoshi Yoshioka, Shinsuke Iida, Noriko Doki, Tatsuo Oyake, Tatsuo Ichinohe, Yoshinobu Kanda, (unknown), Hiroyuki Takamatsu, (unknown)	11
5	Predictive and risk factor analysis for bloodstream infection in high-risk hematological patients with febrile neutropenia: post-hoc analysis from a prospective, large-scale clinical study 2021 ·International Journal of Hematology ·Akinao Okamoto, Yoshinobu Kanda, Shun‐ichi Kimura, Tatsuo Oyake, Kazuo Tamura, (unknown)	6
6	Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation 2021 ·Transplantation and Cellular Therapy ·Masaaki� Hotta, Atsushi� Satake, Hideaki� Yoshimura, Shinya� Fujita, Yuta Katayama, Shuichi Ota, Hitoshi Hanamoto, Tatsuo Oyake, Shigeki Ito, Masaya Okada, Takahisa� Nakanishi, Tomoki� Ito, Kazuyoshi� Ishii, Shosaku� Nomura	6
7	Fungal biomarker monitoring and CT scans for early detection of invasive fungal disease in neutropenic hematological patients 2021 ·Journal of Infection ·Shun‐ichi Kimura, Yoshinobu Kanda, Tatsuo Oyake, Hiroki Yamaguchi, Shin‐ichiro Fujiwara, Akinao Okamoto, Hiroyuki Fujita, Yoshio Saburi, Kazuo Tamura	1
8	Efficacy and safety of micafungin in empiric and D-index-guided early antifungal therapy for febrile neutropenia; A subgroup analysis of the CEDMIC trial 2020 ·International Journal of Infectious Diseases ·Shun‐ichi Kimura, Yoshinobu Kanda, Masaki Iino, Takahiro Fukuda, Emiko Sakaida, Tatsuo Oyake, Hiroki Yamaguchi, Shin‐ichiro Fujiwara, (unknown), Akinao Okamoto, Hiroyuki Fujita, Yasushi Takamatsu, Yoshio Saburi, Itaru Matsumura, Jun Yamanouchi, Souichi Shiratori, Moritaka Gotoh, Shingen Nakamura, Kazuo Tamura	5
9	Doripenem versus meropenem as first-line empiric therapy of febrile neutropenia in patients with acute leukemia: a prospective, randomized study 2019 ·Annals of Hematology ·Tatsuo Oyake, (unknown), (unknown), (unknown), (unknown), Ichiro Hanamura, (unknown), (unknown), Shugo Kowata, Shigeki Ito, Yoji Ishida	2
10	Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma 2018 ·International Journal of Hematology ·Satoshi Yamasaki, Dai Chihara, Sung Won Kim, (unknown), Shuichi Mizuta, (unknown), Takaaki Chou, Takahisa Yamane, Hitoji Uchiyama, Tatsuo Oyake, Katsuhiro Miura, Bungo Saito, Hirofumi Taji, Hirohisa Nakamae, Toshihiro Miyamoto, Takahiro Fukuda, Junya Kanda, Yoshiko Atsuta, Ritsuro Suzuki	7
11	Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial 2015 ·European Journal Of Haematology ·Tatsuo Oyake, Shugo Kowata, Kazunori Murai, Shigeki Ito, Tomoaki Akagi, Kohmei Kubo, Kenichi Sawada, Yoji Ishida	16
12	Deguelin suppresses cell proliferation via the inhibition of survivin expression and STAT3 phosphorylation in HTLV-1-transformed T cells 2009 ·Leukemia Research ·Shigeki Ito, Tatsuo Oyake, Kazunori Murai, Yoji Ishida	23
13	Absence of pseudomembranes inClostridium difficile-associated diarrhea in patients using immunosuppression agents 2008 ·Scandinavian Journal of Gastroenterology ·Ken‐ichi Nomura, Yoshiko Fujimoto, (unknown), (unknown), (unknown), Kazumi Sato, Tatsuo Oyake, Shugo Kowata, Hideyuki Konishi, Toshikazu Yoshikawa, Yoji Ishida, Masafumi Taniwaki, (unknown)	53
14	Clinical significance of high-Km 5′-nucleotidase (cN-II) mRNA expression in high-risk myelodysplastic syndrome 2007 ·Leukemia Research ·(unknown), Takeshi Sugawara, Tatsuo Oyake, (unknown), (unknown), (unknown), (unknown), Shigeki Ito, Kazunori Murai, Yoji Ishida	12
15	Aberrant maspin expression in gallbladder epithelium is associated with intestinal metaplasia in patients with cholelithiasis 2006 ·Journal of Clinical Pathology ·Chihaya Maesawa, Satoshi Ogasawara, Akiko Yashima‐Abo, Toshimoto Kimura, Kazuo Kotani, Shinichiro Masuda, Yuki Nagata, Takeshi Iwaya, (unknown), Tatsuo Oyake, Yuji Akiyama, Hidenobu Kawamura, Takahiro Masuda	21
16	Successful Treatment with Cyclosporine and High-Dose Gamma Immunoglobulin for Persistent Parvovirus B19 Infection in a Patient with Refractory Autoimmune Hemolytic Anemia 2004 ·International Journal of Hematology ·Shigeki Ito, Tatsuo Oyake, (unknown), Takeshi Sugawara, Kazunori Murai, Yoji Ishida	3
17	Clinical and Biological Significance of CD56 Antigen Expression in Acute Promyelocytic Leukemia 2004 ·Leukemia & lymphoma ·Shigeki Ito, Yoji Ishida, Tatsuo Oyake, (unknown), (unknown), Shugo Kowata, (unknown), (unknown), Takeshi Sugawara, (unknown), (unknown), Kazunori Murai	27
18	Myelodysplastic Syndrome with Bone Marrow Hypoplasia Is Associated with Much Higher Frequency of Apoptosis in CD 34+ Cells. 2004 ·Blood ·Tatsuo Oyake, Shigeki Ito, Shugo Kowata, Kazunori Murai, Yoji Ishida	0
19	Incubation With IgE Increases Cholinergic Neurotransmission in Human Airways in Vitro 1996 ·American Journal of Respiratory and Critical Care Medicine ·M. Ichinose, M. Miura, M Tomaki, Tatsuo Oyake, (unknown), (unknown), (unknown), Ken Shirato	28
20	A Neurokinin 1-Receptor Antagonist Improves Exercise-Induced Airway Narrowing in Asthmatic Patients 1996 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), M. Miura, Haruo Yamauchi, Naoko Kageyama, M Tomaki, Tatsuo Oyake, (unknown), (unknown), H. Miki, G Tamura, K Shirato	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact